Prognostic Value of Myocardial Infarct Size and Contractile Reserve Using Magnetic Resonance Imaging

Journal of the American College of Cardiology

Volumn 54, Issue 19, 2009, Pages 1770-1777

  Kelle, Sebastian ^a   Roes, Stijntje D ^b   Klein, Christoph ^a   Kokocinski, Thomas ^a   de Roos, Albert ^b   Fleck, Eckart ^a   Bax, Jeroen J ^b   Nagel, Eike ^c  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

cardiac magnetic resonance; contractile reserve; delayed enhancement; prognosis

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; GADOLINIUM PENTETATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; WARFARIN;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTINUOUS INFUSION; CORONARY ARTERY DISEASE; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE VOLUME; HEART LEFT VENTRICLE WALL MOTION; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; HIGH RISK PATIENT; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REST; SCAR; SCORING SYSTEM;

AGED; CARDIOTONIC AGENTS; CICATRIX; CONFOUNDING FACTORS (EPIDEMIOLOGY); DIURETICS; DOBUTAMINE; FEMALE; FOLLOW-UP STUDIES; GADOLINIUM; GERMANY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KAPLAN-MEIERS ESTIMATE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; NETHERLANDS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 70350491373     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.07.027     Document Type: Article

References (36)

1. Sharir T., Germano G., Kang X., et al. Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction. J Nucl Med 42 (2001) 831-837
2. White H.D., Norris R.M., Brown M.A., Brandt P.W., Whitlock R.M., and Wild C.J. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 76 (1987) 44-51
3. Wu E., Ortiz J.T., Tejedor P., et al. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study. Heart 94 (2008) 730-736
4. Roes S.D., Kelle S., Kaandorp T.A., et al. Comparison of myocardial infarct size assessed with contrast-enhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction. Am J Cardiol 100 (2007) 930-936
5. Williams M.J., Odabashian J., Lauer M.S., Thomas J.D., and Marwick T.H. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. J Am Coll Cardiol 27 (1996) 132-139
6. Sandstede J.J., Bertsch G., Beer M., et al. Detection of myocardial viability by low-dose dobutamine cine MR imaging. Magn Reson Imaging 17 (1999) 1437-1443
7. Dendale P., Franken P.R., Holman E., Avenarius J., van der Wall E.E., and de Roos A. Validation of low-dose dobutamine magnetic resonance imaging for assessment of myocardial viability after infarction by serial imaging. Am J Cardiol 82 (1998) 375-377
8. Wellnhofer E., Olariu A., Klein C., et al. Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery. Circulation 109 (2004) 2172-2174
9. Schinkel A.F., Poldermans D., Elhendy A., and Bax J.J. Prognostic role of dobutamine stress echocardiography in myocardial viability. Curr Opin Cardiol 21 (2006) 443-449
10. Nagel E., Lorenz C., Baer F., et al. Stress cardiovascular magnetic resonance: consensus panel report. J Cardiovasc Magn Reson 3 (2001) 267-281
11. van der Geest R.J., Buller V.G., Jansen E., et al. Comparison between manual and semiautomated analysis of left ventricular volume parameters from short-axis MR images. J Comput Assist Tomogr 21 (1997) 756-765
12. Cerqueira M.D., Weissman N.J., Dilsizian V., et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105 (2002) 539-542
13. Wu E., Judd R.M., Vargas J.D., Klocke F.J., Bonow R.O., and Kim R.J. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 357 (2001) 21-28
14. Kaandorp T.A., Bax J.J., Lamb H.J., et al. Which parameters on magnetic resonance imaging determine Q waves on the electrocardiogram?. Am J Cardiol 95 (2005) 925-929
15. Kwong R.Y., and Korlakunta H. Diagnostic and prognostic value of cardiac magnetic resonance imaging in assessing myocardial viability. Top Magn Reson Imaging 19 (2008) 15-24
16. Wu K.C., Zerhouni E.A., Judd R.M., et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 97 (1998) 765-772
17. Hombach V., Grebe O., Merkle N., et al. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J 26 (2005) 549-557
18. Gerber B.L., Garot J., Bluemke D.A., Wu K.C., and Lima J.A. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 106 (2002) 1083-1089
19. van der Burg A.E., Bax J.J., Boersma E., Pauwels E.K., van der Wall E.E., and Schalij M.J. Impact of viability, ischemia, scar tissue, and revascularization on outcome after aborted sudden death. Circulation 108 (2003) 1954-1959
20. Bello D., Fieno D.S., Kim R.J., et al. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol 45 (2005) 1104-1108
21. Yan A.T., Shayne A.J., Brown K.A., et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 114 (2006) 32-39
22. Schmidt A., Azevedo C.F., Cheng A., et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 115 (2007) 2006-2014
23. Kwong R.Y., Sattar H., Wu H., et al. Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction. Circulation 118 (2008) 1011-1020
24. Kim H.W., Klem I., Shah D.J., et al. Unrecognized non-Q-wave myocardial infarction: prevalence and prognostic significance in patients with suspected coronary disease. PLoS Med 6 (2009) e1000057
25. Geskin G., Kramer C.M., Rogers W.J., et al. Quantitative assessment of myocardial viability after infarction by dobutamine magnetic resonance tagging. Circulation 98 (1998) 217-223
26. Baer F.M., Voth E., Schneider C.A., Theissen P., Schicha H., and Sechtem U. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. Circulation 91 (1995) 1006-1015
27. Baer F.M., Theissen P., Schneider C.A., et al. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol 31 (1998) 1040-1048
28. Rizzello V., Poldermans D., Schinkel A.F., et al. Long term prognostic value of myocardial viability and ischaemia during dobutamine stress echocardiography in patients with ischaemic cardiomyopathy undergoing coronary revascularisation. Heart 92 (2006) 239-244
29. Rambaldi R., Bax J.J., Rizzello V., et al. Post-systolic shortening during dobutamine stress echocardiography predicts cardiac survival in patients with severe left ventricular dysfunction. Coron Artery Dis 16 (2005) 141-145
30. Sicari R., Picano E., Cortigiani L., et al. Prognostic value of myocardial viability recognized by low-dose dobutamine echocardiography in chronic ischemic left ventricular dysfunction. Am J Cardiol 92 (2003) 1263-1266
31. Sawada S., Bapat A., Vaz D., et al. Incremental value of myocardial viability for prediction of long-term prognosis in surgically revascularized patients with left ventricular dysfunction. J Am Coll Cardiol 42 (2003) 2099-2105
32. Kaandorp T.A., Bax J.J., Schuijf J.D., et al. Head-to-head comparison between contrast-enhanced magnetic resonance imaging and dobutamine magnetic resonance imaging in men with ischemic cardiomyopathy. Am J Cardiol 93 (2004) 1461-1464
33. Kraitchman D.L., Sampath S., Castillo E., et al. Quantitative ischemia detection during cardiac magnetic resonance stress testing by use of FastHARP. Circulation 107 (2003) 2025-2030
34. Bree D., Wollmuth J.R., Cupps B.P., et al. Low-dose dobutamine tissue-tagged magnetic resonance imaging with 3-dimensional strain analysis allows assessment of myocardial viability in patients with ischemic cardiomyopathy. Circulation 114 (2006) I-33-6
35. Fernandes V.R.S., Wu K.C., Rosen B.D., et al. Enhanced infarct border zone function and altered mechanical activation predict inducibility of monomorphic ventricular tachycardia in patients with ischemic cardiomyopathy. Radiology 245 (2007) 712-719
36. Roes S.D., Borleffs C.J.W., van der Geest R.J., et al. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator. Circ Cardiovasc Imaging 2 (2009) 183-190